Kyprolis 60 MG vials
Ended Awarded
- Contract number
- SPE2DB26FTH13
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,794
Award facts
- Contract value 100% obligated
- $10,794.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,794.36 for Kyprolis 60 mg vials on October 29, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award issued under the company's existing indefinite delivery contract with DLA Troop Support Medical. Kyprolis (carfilzomib) is a proteasome inhibitor used in cancer treatment, reflecting the critical pharmaceutical support that AmerisourceBergen provides to military and federal healthcare systems. The performance location for this delivery is the company's corporate office in Conshohocken, Pennsylvania.
This delivery order is a child contract issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through December 2026. The prime IDV serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this strategic contracting vehicle, AmerisourceBergen continues to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems as a critical pharmaceutical distributor within the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FTH13?
SPE2DB26FTH13 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FTH13 worth?
The government has obligated $10,794 on SPE2DB26FTH13.
Is contract SPE2DB26FTH13 an order under another contract?
Yes. SPE2DB26FTH13 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB26FTH13 competed?
The extent of competition for SPE2DB26FTH13 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award